跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
CANDESARTAN/HIDROCLOROTIAZIDA COMBIX 32 MG/ 12,5 MG COMPRIMIDOS EFG
Approved
STANDARD
CANDESARTAN/HIDROCLOROTIAZIDA COMBIX 32 MG/ 12,5 MG COMPRIMIDOS EFG
Laboratorios Combix S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 2, 2024
Approval ID
26cfe3b9870c9e30
Company
Laboratorios Combix S.L.U.
Type
Standard
Approval Details
Approval Id
26cfe3b9870c9e30
Drug Cima Aemps Name
CANDESARTAN/HIDROCLOROTIAZIDA COMBIX 32 MG/ 12,5 MG COMPRIMIDOS EFG
Register Number
89755
Holder Company Name
Laboratorios Combix S.L.U.
Marketing Company Name
Laboratorios Combix S.L.U.
Authorization Date
2024-08-02
Dosage Form
COMPRIMIDO
Dose
32 mg/ 12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Laboratorios Combix S.L.U.
Active Ingredients
CANDESARTAN CILEXETILO
32 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 2, 2024
Approval ID
26cfe3b9870c9e30
Type
Standard
Back to CIMA-AEMPS Approvals
CANDESARTAN/HIDROCLOROTIAZIDA COMBIX 32 MG/ 12,5 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details